Search

everythinglearnresearchcommunity

for

Search:↓

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

DHT, a testosterone byproduct, causes male pattern baldness.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

Treat pattern hair loss with finasteride and topical minoxidil.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Women with PCOS have altered brain structure and reduced cognitive performance.

Hormones significantly affect hair growth and loss, requiring personalized treatment.

PCOS may increase the risk of certain cancers.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Future acne treatments should aggressively target inflammation to prevent scarring.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Spironolactone helps regrow hair in women with hair loss.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.